Infusion Therapy for COVID-19

COVID-19

Please Note: this therapy is only offered at our Grand Rapids, MI location at this time.

 

What is COVID-19?

According to the CDC, COVID-19 is a respiratory disease caused by SARS-CoV-2, a new coronavirus discovered in 2019. The virus is thought to spread mainly from person to person through respiratory droplets produced when an infected person coughs, sneezes, or talks. Some people who are infected may not have symptoms. For people who have symptoms, illness can range from mild to severe. Adults 65 years and older and people of any age with underlying medical conditions are at higher risk for severe illness. People 12 years and older should get COVID-19 vaccines to prevent getting and spreading the illness.

How IV Therapy Works for COVID-19

In 2021, the FDA authorized an Emergency Use Authorization (EUA) of monoclonal antibody IV therapy. Intravenous (IV) therapy delivers medication directly into your bloodstream. Monoclonal antibodies are designed to block viral attachment and entry into human cells to neutralize the virus. It is designed to limit viral replication and may be effective for the treatment of COVID-19 in patients who are at high risk for severe COVID-19.

Monoclonal antibody treatment is for people who have tested positive for COVID-19 and have mild to moderate symptoms. These treatments are allowed by the U.S. Food and Drug Administration under the EUA while clinical studies continue to look at their usefulness and safety. For more information, please refer to the Patient Fact Sheet or Provider Fact Sheet.

Infusion Associates is involved in the NIH COVID-19 Research Study, and is currently enrolling patients in Michigan who qualify for the study. The study team hopes to find out if giving anti-SARS-CoV-2 hyperimmunoglobulin (hIVIG) to people early in their infection with COVID-19, before the body has had a chance to make its own antibodies, can help prevent bad effects from COVID-19 and enable them to stay out of the hospital. For more information about this study, please visit the study page.

How can I get monoclonal antibody infusion therapy if I have COVID-19?

Monoclonal antibodies are prescribed by a healthcare professional. For those at high risk or already diagnosed with COVID-19, discuss treatment options with your doctor. If your doctor prescribes monoclonal antibody therapy, you can ask them to receive this at Infusion Associates by following the steps below:

  1. Ask your healthcare provider to fax us a completed order form for your medication, clinical notes, demographics and your insurance card to (616) 818-4484.
  2. Providers can find the monoclonal antibody therapy order form here.
  3. Once we receive this documentation, we will then verify benefits, obtain any required prior authorizations, and contact you to schedule an appointment.

Are there any side effects?

People who receive monoclonal antibody treatment may experience pain at the infusion site, including:

  • Skin bruising
  • Soreness
  • Swelling
  • Possible infection

More serious side effects include:

  • Interferes with your body’s ability to fight off a future COVID-19 infection
  • Reduces your body’s immune response to a COVID-19 vaccine

If Your Doctor Has Recommended IV Therapy for COVID-19, Let Infusion Associates Help You

At Infusion Associates, we provide medically-prescribed infusion therapy for patients with chronic conditions in a welcoming and friendly environment. Our team of healthcare professionals is fully committed to making the experience as comfortable as possible for you or your patients. We always inform patients of any potential side effects and answer all their questions before starting treatment, and have a nurse practitioner on site to answer medical questions regarding the treatment they are receiving.

If you would like to refer a patient to us or want to inquire about the treatments we offer, you can contact us by calling us at (616) 954-0600 or filling out this form.